| scholarly article | Q13442814 |
| P50 | author | Chen Yu | Q63430608 |
| Rebecca Kaye | Q87777060 | ||
| Charles N Serhan | Q87981947 | ||
| P2093 | author name string | Daniel R Saban | |
| Darlene A Dartt | |||
| Robin R Hodges | |||
| Nancy J Reyes | |||
| Rose Mathew | |||
| William Swift | |||
| Nora Botten | |||
| P2860 | cites work | Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes | Q38179488 |
| T helper subsets in allergic eye disease | Q38238831 | ||
| Trends in prevalence and treatment of ocular allergy | Q38239233 | ||
| Linking immune responses with fibrosis in allergic eye disease | Q38563744 | ||
| Corneal complications of vernal keratoconjunctivitis. | Q38563749 | ||
| Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms | Q39088075 | ||
| Mucus fishing syndrome: case report and new treatment option | Q39122314 | ||
| Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology | Q39163938 | ||
| Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors | Q39197238 | ||
| Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics | Q40317977 | ||
| Experimental model of allergic conjunctivitis to ragweed in guinea pig. | Q40684018 | ||
| A novel murine model of allergic conjunctivitis | Q40860360 | ||
| Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. | Q41386825 | ||
| Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses | Q41864170 | ||
| Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. | Q42173370 | ||
| Epidermal growth factor receptor signaling mediates regranulation of rat nasal goblet cells | Q43634089 | ||
| Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis | Q44491491 | ||
| Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. | Q50537818 | ||
| Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. | Q54596780 | ||
| Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators | Q58778591 | ||
| Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. | Q64960917 | ||
| Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen | Q67657662 | ||
| Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis | Q72560783 | ||
| Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion | Q77425400 | ||
| Induction and Characterization of the Allergic Eye Disease Mouse Model | Q89339083 | ||
| Mucus fishing syndrome | Q93637908 | ||
| Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
| Systemic side effects of eye drops: a pharmacokinetic perspective | Q28066720 | ||
| Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation | Q28218126 | ||
| Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions | Q28264433 | ||
| Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke | Q31766790 | ||
| Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators | Q33437576 | ||
| The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation | Q34230865 | ||
| Allergic conjunctivitis: update on pathophysiology and prospects for future treatment | Q34382475 | ||
| Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins | Q34462636 | ||
| Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses | Q34731337 | ||
| Ocular allergy modulation to hi-dose antigen sensitization is a Treg-dependent process | Q35005963 | ||
| The polymeric mucin Muc5ac is required for allergic airway hyperreactivity | Q35098892 | ||
| The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation | Q35145988 | ||
| Animal models of allergic and inflammatory conjunctivitis. | Q35583047 | ||
| Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease | Q35672575 | ||
| IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells | Q35831266 | ||
| Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease | Q35917624 | ||
| Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion | Q36035030 | ||
| Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines | Q36300034 | ||
| Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation | Q36495510 | ||
| Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa | Q37016912 | ||
| Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion | Q37092941 | ||
| Functions of ocular surface mucins in health and disease | Q37152910 | ||
| Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy | Q37217082 | ||
| Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring | Q37277234 | ||
| Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion | Q37338329 | ||
| Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells | Q37399828 | ||
| Modulation of conjunctival goblet cell function by inflammatory cytokines | Q37424310 | ||
| Management of seasonal allergic conjunctivitis: guide to therapy | Q37954005 | ||
| Diagnostics and new developments in the treatment of ocular allergies | Q37989819 | ||
| Allergic conjunctivitis: an update on diagnosis and management | Q38131339 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| resolvin D1 | Q60998703 | ||
| P304 | page(s) | 145-153 | |
| P577 | publication date | 2018-10-02 | |
| P1433 | published in | Mucosal Immunology | Q15817743 |
| P1476 | title | Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model | |
| P478 | volume | 12 |
| Q90638495 | Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose |
| Q90235040 | Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells |
| Q90341440 | Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis |
| Q90356613 | VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis |
Search more.